Gall Matthew — SEC Form 4 filings
SEC reporting owner CIK 1816194. 7 Form 4 filings on record with FilingPulse; latest filed 2026-05-05.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-03-08 to 2026-05-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 5,000 shares, $38,635 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: purchase of 5,000 shares @ $7.73 ($38,635) in iTeos Therapeutics, Inc., filed 2024-11-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| iTeos Therapeutics, Inc. (ITOS) | Chief Financial Officer | 4 | 1 leg · 5,000 sh · $38,635 | — | 9 |
| Kalaris Therapeutics, Inc. (KLRS) | Chief Financial Officer | 2 | — | — | 2 |
| Tango Therapeutics, Inc. (TNGX) | Chief Financial Officer | 1 | — | — | 2 |
Form 4 filings — Gall Matthew
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-05 | 4 | Tango Therapeutics, Inc. (TNGX) | Grant/award (A): 40,000 @ $0 · Grant/award (A): 240,000 (derivative) @ $0 | EDGAR |
| 2026-03-20 | 4 | Kalaris Therapeutics, Inc. (KLRS) | Grant/award (A): 95,000 (derivative) @ $0 | EDGAR |
| 2025-11-03 | 4 | Kalaris Therapeutics, Inc. (KLRS) | Grant/award (A): 235,000 (derivative) @ $0 | EDGAR |
| 2025-08-29 | 4 | iTeos Therapeutics, Inc. (ITOS) | Code (U): 89,429 · Disposition to issuer (D): 9,063 (derivative) · Disposition to issuer (D): 135,937 (derivative) · Disposition to issuer (D): 42,388 (derivative) · Disposition to issuer (D): 8,123 (derivative) · Disposition to issuer (D): 252,135 (derivative) | EDGAR |
| 2025-03-11 | 4 | iTeos Therapeutics, Inc. (ITOS) | Grant/award (A): 24,000 @ $0 · Grant/award (A): 145,000 (derivative) @ $0 | EDGAR |
| 2024-11-19 | 4 | iTeos Therapeutics, Inc. (ITOS) | Purchase (P): 5,000 @ $7.73 | EDGAR |
| 2024-03-08 | 4 | iTeos Therapeutics, Inc. (ITOS) | Grant/award (A): 163,200 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1816194 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →